Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

Regarding clinical cure, our meta-analysis showed a trend towards a higher cure rate (not statistically significant) in the cefiderocol group; however, this trend was not observed when considering only the RCTs, although cefiderocol still demonstrated non-inferiority in this outcome compared to BAT.
The curves showed a trend of decreasing hearing thresholds with increasing α-Klotho levels, but no non-linear relationship was observed. 3.4 Hearing loss risk assessment Table 4 presents adjusted odds ratios ( OR s) and their 95% confidence intervals ( CI s) for the relationship between serum α-Klotho levels and hearing loss in the study population.
In phase II KEYNOTE-100 study, patients with OCCC showed a trend toward greater benefits from pembrolizumab (n=19, ORR=15.8%, 95% CI: 3.4% to 39.6%). 15 In phase III study of platinum-resistant OC, patients with OCCC experienced longer OS with nivolumab compared with chemotherapy (gemcitabine or pegylated liposomal doxorubicin) (HR: 0.78; 95% CI: 0.46 to 1.32).
IVIM D* showed a trend toward higher values in the core and recanalized penumbra compared to their respective control regions, but these effects did not survive correction for multiple comparisons (IVIM D* core vs. control: t[15] = 2.41, p = 0.088, Cohens’ d = 0.60; IVIM D* recanalized penumbra vs. control : t[20] = 2.47, p = 0.068, Cohens’ d = 0.54; IVIM D* core vs. recanalized penumbra : t[5] = 2.10, p = 0.16).